Medicare Enrolled
Dr. Liliana Bustamante, MD
Hematology · Cape Coral, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bustamante from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bustamante?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bustamante
Dr. Liliana Bustamante is a hematology specialist in Cape Coral, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Bustamante performed 205,163 Medicare services across 4,895 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bustamante received a total of $34,073 from 79 pharmaceutical and/or device companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bustamante is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 20% volume in FL
$34,073 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 119232 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗205,163
Medicare services
Top 20% in FL for hematology
4,895
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 33,601 | $43 | $137 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
20,000 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 19,110 | $1 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
18,693 | $0 | $12 |
| Nivolumab injection (Opdivo) | 14,600 | $23 | $72 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,260 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
11,520 | $0 | $2 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,440 | $38 | $110 |
| Paclitaxel chemotherapy injection | 9,572 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 8,040 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
7,660 | $6 | $23 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
6,570 | $0 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,127 | $0 | $3 |
| Romiplostim injection, 10 micrograms An injection of romiplostim containing 10 micrograms of the medication. |
3,448 | $73 | $197 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
3,288 | $36 | $108 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,608 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,250 | $1 | $28 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,111 | $8 | $9 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
1,470 | $5 | $113 |
| Injection, leucovorin calcium, per 50 mg | 1,370 | $3 | $12 |
| Injection, fulvestrant, 25 mg | 1,260 | $8 | $132 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
999 | $68 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 960 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
862 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
775 | $102 | $378 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
741 | $2 | $7 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
715 | $11 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
581 | $99 | $339 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 533 | $3 | $205 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
392 | $2 | $41 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
266 | $1 | $3 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
263 | $2 | $13 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
255 | $22 | $79 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
247 | $49 | $189 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
230 | $23 | $84 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
202 | $10 | $42 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
186 | $2 | $7 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
179 | $7 | $69 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
169 | $52 | $178 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
145 | $26 | $89 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
143 | $1 | $6 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
133 | $18 | $59 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
131 | $55 | $206 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
116 | $25 | $156 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
115 | $2 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
106 | $16 | $56 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
104 | $134 | $637 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $133 | $562 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
85 | $16 | $56 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $132 | $453 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
75 | $29 | $156 |
| New patient office visit, complex (60-74 min) | 74 | $166 | $585 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
47 | $3 | $11 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
46 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
45 | $140 | $474 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
24 | $1 | $7 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
20 | $5 | $20 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
16 | $4 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $65 | $197 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
87.5% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,073
Total received (2018-2024)
Avg $4,868/year across 7 years
Top 14% in FL for hematology
79
Companies
758
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,777 (46.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,668 (40.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,628 (13.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,033
2023
$15,847
2022
$1,717
2021
$4,073
2020
$1,128
2019
$1,495
2018
$2,781
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$14,476
Eli Lilly and Company
$1,875
Bayer HealthCare Pharmaceuticals Inc.
$1,873
G1 Therapeutics, Inc.
$1,520
E.R. Squibb & Sons, L.L.C.
$1,330
Bayer Healthcare Pharmaceuticals Inc.
$1,167
Janssen Biotech, Inc.
$1,055
Novartis Pharmaceuticals Corporation
$978
PFIZER INC.
$843
Merck Sharp & Dohme LLC
$744
Genentech USA, Inc.
$519
Incyte Corporation
$496
Merck Sharp & Dohme Corporation
$468
Celgene Corporation
$449
Seagen Inc.
$414
Gilead Sciences, Inc.
$391
Astellas Pharma US Inc
$384
AstraZeneca Pharmaceuticals LP
$310
GlaxoSmithKline, LLC.
$272
Exelixis Inc.
$269
BeiGene USA, Inc.
$261
Daiichi Sankyo Inc.
$236
NanoString Technologies, Inc.
$232
GENZYME CORPORATION
$221
Mirati Therapeutics, Inc.
$218
Lilly USA, LLC
$212
Agios Pharmaceuticals, Inc.
$206
Eisai Inc.
$205
ARRAY BIOPHARMA INC
$197
TAIHO ONCOLOGY, INC.
$197
JAZZ PHARMACEUTICALS INC.
$190
CTI BioPharma Corp.
$140
Sirtex Medical Inc
$113
Foundation Medicine, Inc.
$110
PORTOLA PHARMACEUTICALS, INC.
$97
ACELL, INC.
$94
AbbVie, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$88
ABBVIE INC.
$83
TerSera Therapeutics LLC
$79
Intera Oncology, Inc
$69
AbbVie Inc.
$49
EMD Serono, Inc.
$46
Pharmacyclics LLC, An AbbVie Company
$44
Merz North America, Inc.
$41
GE HEALTHCARE
$40
Puma Biotechnology, Inc.
$38
Deciphera Pharmaceuticals Inc.
$36
MERZ NORTH AMERICA, INC.
$35
MorphoSys, US Inc.
$32
ImmunoGen, Inc.
$32
SOBI, INC
$30
INSYS Therapeutics Inc
$28
Sumitomo Pharma America, Inc.
$27
SpringWorks Therapeutics, Inc.
$25
Heron Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
Adaptive Biotechnologies Corporation
$22
Pharmacosmos Therapeutics Inc.
$21
Alnylam Pharmaceuticals Inc.
$20
CSL Behring
$20
Seattle Genetics, Inc.
$19
Verastem, Inc.
$18
Jazz Pharmaceuticals Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Genmab U.S., Inc.
$17
Spectrum Pharmaceuticals Inc.
$15
Otsuka America Pharmaceutical, Inc.
$15
R-Pharm US LLC
$15
Aurobindo Pharma USA, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
PharmaEssentia USA Corporation
$14
Taiho Oncology, Inc.
$13
Octapharma USA, Inc.
$12
Horizon Pharma plc
$12
Myovant Sciences Inc.
$11
Dendreon Pharmaceuticals LLC
$11
Veracyte, Inc.
$4
Top 3 companies account for 53.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BEVYXXA · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · HEMGENIX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INTERA · Ixempra · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Morphabond ER · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Revlimid · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAFINLAR · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XTANDI · Xeomin · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (46%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
13
Per 100K population
1.6
County median income
$73,099
Nearest hospital
CAPE CORAL HOSPITAL
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bustamante is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), with speaking/promotional industry engagement in the top 14% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bustamante experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Bustamante performed 33,601 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bustamante receive payments from pharmaceutical companies?
Yes. Dr. Bustamante received a total of $34,073 from 79 companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bustamante's costs compare to other hematologists in Cape Coral?
Dr. Bustamante's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bustamante) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Cape Coral
Browse hematologists in Cape Coral ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology